藥 物 回 收
|
| |
| The United States: Haleon issues voluntary nationwide recall of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult products due to microbial contamination (English only) |
| |
The US Food and Drug Administration (FDA) announces that Haleon is voluntarily recalling eight lots of Robitussin Honey CF Max Day Adult and Robitussin Honey CF Max Nighttime Adult to the consumer level. The products are being recalled due to microbial contamination. The affected products are:
- Robitussin Honey CF Max Day Adult 4oz (lot number: T10810)
- Robitussin Honey CF Max Day Adult 8oz (lot number: T08730, T08731, T08732, T08733, T10808)
- Robitussin Honey CF Max NT Adult 8oz (lot number: T08740, T08742)
In immunocompromised individuals, the use of the affected products could potentially result in severe or life-threatening adverse events such as fungemia or disseminated fungal infection. In non-immunocompromised consumers, the population most likely to use the products, life-threatening infections are not likely to occur. However, the occurrence of an infection that may necessitate medical intervention cannot be completely ruled out.
To date, Haleon has not received any reports of adverse events related to this recall.
Please refer to the following website in FDA for details:
http://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/haleon-issues-voluntary-nationwide-recall-robitussin-honey-cf-max-day-adult-and-robitussin-honey-cf
In Hong Kong, the above products are not registered pharmaceutical products.
Ends/Thursday, Jan 25, 2024
Issued at HKT 15:30
|
| |
